Kauffman Michael

Kauffman Michael is listed in filings as Director at Kezar Life Sciences, Inc.. This profile follows SEC Form 4 activity through May 11, 2026, including sale activity. Recent filings connect the profile to Kezar Life Sciences, Inc. (KZR), Verastem, Inc. (VSTM), and Kyntra Bio, Inc. (KYNB). The current snapshot covers public activity from Jun 20, 2024 to May 11, 2026. Reported amounts are shown as $92.4K to $44.3K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.